Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075051 Target Snapshot

Dihydrofolate reductase · SINGLE PROTEIN · Bos taurus

370Compounds
88Assays
4Approved Drugs
364.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P00376. Use UniProt P00376 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00376 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dihydrofolate reductase as ChEMBL target CHEMBL1075051, mapped to UniProt P00376. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dihydrofolate reductase
SINGLE PROTEIN · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL1075051
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P00376
Dihydrofolate reductase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dihydrofolate reductase is the right protein anchor across sources, using UniProt P00376 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDihydrofolate reductase
UniProt AccessionP00376
Component TypeProtein
Sequence Length187 aa

Dihydrofolate reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dihydrofolate reductase, mapped to UniProt P00376. Sequence length is 187 aa.

Mapped IDP00376
Review nameDihydrofolate reductase
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC50364.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL34259 8.77 IC50 1.7 Approved
CHEMBL1800937 8.64 IC50 2.3 Preclinical
CHEMBL3115740 8.4 IC50 4.0 Preclinical
CHEMBL155016 8.27 IC50 5.4 Preclinical
CHEMBL154152 8.27 IC50 5.4 Preclinical
CHEMBL1801203 8.25 IC50 5.6 Preclinical
CHEMBL1801200 8.21 IC50 6.1 Preclinical
CHEMBL1800946 8.16 IC50 6.9 Preclinical
CHEMBL1800939 8.14 IC50 7.2 Preclinical
CHEMBL1800944 8.12 IC50 7.6 Preclinical
Distribution

pChEMBL Value Distribution

58
5.0
29
5.5
47
6.0
5
6.5
26
7.0
15
7.5
18
8.0
2
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

METHOTREXATE
CHEMBL34259
Approved 1953
PYRIMETHAMINE
CHEMBL36
Approved 1953
CHLOROQUINE
CHEMBL76
Approved 1949
Assay Landscape

Assay Landscape

88
Total Assays
250
Tested Compounds
2
Assay Types
Binding — 87 assays, 250 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 60 182 6.2
single protein format 26 63 5.4
tissue-based format 1 5 6.2
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine